Intensification Program News Today

Tie tonight for our top story, so what we will present to you are series of top stories including an overwhelming vote in the house of representatives to rebuke the president of the United States. President trump was on the losing end of 245182 on a resolution to terminate the president s declared emergency at the southern border to build his wall. The author of that resolution congressman wakeen castro will joins us and will also be one of the members of congress who will question Michael Cohen...

Rachel, youre going to have get here during the testimony maybe. Im hoping theres a lunch break, dinner break. Thats the thing. Theyve said that theyre not really scheduling a lunch break as of now which sometimes happens in these hearings, and they will break only for votes. And so that can give us at least a 20 to 25 minute window to rush from the pajama place to here. Well, the good thing about the way we do tv is that the pajama place can always exist from the waist down. Who knows, i might ...

/PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce that Dr. Juan Torres has recently...

/PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce that Dr. Juan Torres has recently...

/PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce that Jeffery Baker, Ph.D., Tim...

/PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce that Jeffery Baker, Ph.D., Tim...

Share this article Share this article NEWARK, Del., April 13, 2021 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce that Dr. Gene Schaefer has joined the Institute as NIIMBL Senior Fellow, effective April 5, 2021. Dr. Schaefer joins NIIMBL with over 35 years of experience in the biopharmaceutical field ranging from early stage process development to commercial product support for protein therapeutics. Dr. Gene Schaefer h...